ArticleCommunications chemistry2026
Leveraging Lewis acid catalysis for cascade construction of multisubstituted furans from active methylenes and 3-oxetanone.
Article in Communications chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Leveraging Lewis acid catalysis for cascade construction of multisubstituted furans from active methylenes and 3-oxetanone.Communications chemistry · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The synthesis of multisubstituted furans, those incorporating further functionalizable groups, remains a significant challenge in organic synthesis. These difficulties largely arise from reliance on prefunctionalized substrates, multistep sequences, harsh conditions, and costly catalytic systems. Herein, we report a rapid, efficient, and operationally simple cascade [3 + 2]-annulation that addresses these limitations while delivering step and atom economy. The method exploits readily available and inexpensive active methylene compounds (β-ketoesters, β-diketones, and related derivatives) as C-C-O 1,3-bis-nucleophiles, in combination with 3-oxetanone as a C-C 1,2-bis-electrophile, under catalysis by sustainable and low-cost Fe-salts. This protocol enables the construction of diverse multisubstituted and fused furan architectures, bearing alkyl, cycloalkyl, alkynyl, aryl, and heteroaryl substituents, as well as functional groups derived from nitriles, sulfones, phosphonates, and amides. The synthetic utility of the approach is further demonstrated by the total synthesis of biologically active methylenomycin furans (MMFs) and methylfuroic acid, and formal syntheses of evodone, tubipofuran, menthofuran, maturone, isomaturone, and rabdoketones. Moreover, the method proves highly effective for late-stage diversification, as illustrated by the functionalization of bioactive natural products, including β-ionone, tonalide, progesterone, and pregnenolone. Collectively, this strategy provides a practical, versatile, and sustainable platform for the streamlined synthesis and diversification of multisubstituted furans.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.